SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Procter&Gamble Healt - Quaterly Results

05 May 2022 Evaluate
The March 2022 quarter revenue stood at Rs. 2678.20 millions, up 22.21% as compared to Rs. 2191.50 millions during the corresponding quarter last year.The Net Profit of the company vaulted to 224.41% to Rs. 511.60  millions from Rs. 157.70 millions in the previous quarter.Operating profit surged to 711.20 millions from the corresponding previous quarter of 339.70 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202106 202006 % Var
Sales 2678.20 2191.50 22.21 8185.20 7233.40 13.16 10087.30 8911.96 13.19
Other Income 23.50 32.40 -27.47 100.90 156.80 -35.65 181.00 337.27 -46.33
PBIDT 711.20 339.70 109.36 2187.70 2132.60 2.58 2641.20 2444.80 8.03
Interest 1.40 2.00 -30.00 4.00 6.30 -36.51 8.00 0.00 0.00
PBDT 709.80 337.70 110.19 2183.70 2126.30 2.70 2633.20 2444.80 7.71
Depreciation 61.20 76.70 -20.21 196.10 228.80 -14.29 300.40 206.18 45.70
PBT 648.60 261.00 148.51 1987.60 1897.50 4.75 2332.80 2238.62 4.21
TAX 137.00 103.30 32.62 473.90 468.40 1.17 564.80 545.70 3.50
Deferred Tax -5.90 2.80 -310.71 -10.90 -11.30 -3.54 -49.00 94.90 -151.63
PAT 511.60 157.70 224.41 1513.70 1429.10 5.92 1768.00 1692.92 4.43
Equity 166.00 166.00 0.00 166.00 166.00 0.00 166.00 166.00 0.00
PBIDTM(%) 26.56 15.50 71.32 26.73 29.48 -9.35 26.18 27.43 -4.55

Procter&Gamble Healt Share Price

5021.30 29.00 (0.58%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×